Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

Immune checkpoint inhibitors propelled the field of oncology with clinical responses in many different tumor types. Superior overall survival over chemotherapy has been reported in various metastatic cancers. Furthermore, prolonged disease-free and overall survival have been reported in the adjuvant...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: van Willigen, Wouter W., Bloemendal, Martine, Gerritsen, Winald R., Schreibelt, Gerty, de Vries, I. Jolanda M., Bol, Kalijn F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6174277/
https://ncbi.nlm.nih.gov/pubmed/30327656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02265
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi